-
41
Canadian Consensus Conference on the Management of Viral Hepatitis
Published 2000-01-01“…These proceedings of a consensus conference on the management of viral hepatitis were sponsored by the Canadian Association for Study of the Liver (CASL) and Health Canada. Experts in various aspects of viral hepatitis presented a review of the medical literature on assigned topics. …”
Get full text
Article -
42
HIV Disease Progression to CD4 Count <200 Cells/μL and Death in Saskatoon, Saskatchewan
Published 2013-01-01Get full text
Article -
43
-
44
A Randomized Trial of Yoga for Adolescents with Irritable Bowel Syndrome
Published 2006-01-01Get full text
Article -
45
Contemporary Antiviral Drug Regimens for the Prevention and Treatment of Orolabial and Anogenital Herpes Simplex Virus Infection in the Normal Host: Four Approved Indications and 1...
Published 2003-01-01“…Four drugs: acyclovir, famciclovir, valacyclovir and penciclovir, are currently licensed by the Therapeutics Products Directorate of Health Canada for the management of HSV infections. Although these drugs are only approved for four orolabial and anogenital infections in healthy persons, their efficacy and safety for 13 other related uses in this population have been demonstrated in controlled clinical trials, so called off-label uses. …”
Get full text
Article -
46
Asthma Education Program for First Nations Children: An exemplar of the Knowledge-to-Action Framework
Published 2013-01-01Get full text
Article -
47
-
48
Detection of Antibody to Envelope (E2) Antigen of Hepatitis C Virus
Published 1997-01-01Get full text
Article -
49
In Vitro Activities of Ceftobiprole and Doripenem Tested against Frequently Encountered Aerobic and Facultative Gram-Positive and Gram-Negative Bacterial Pathogens Isolated from Pa...
Published 2009-01-01“…BACKGROUND: In 2008, ceftobiprole was approved by Health Canada for the treatment of patients with complicated skin and skin structure infections including diabetic foot infections; approval of ceftobiprole by the United States Food and Drug Administration is pending. …”
Get full text
Article -
50
-
51
-
52
-
53
Readability and Suitability of COPD Consumer Information
Published 2017-01-01“…COPD inhalers were identified from the Health Canada Drug Product Database. Medication information and instructions for inhaler use were analyzed for readability by seven formulas, with an acceptability threshold of grades 6–8. …”
Get full text
Article -
54
-
55
Spatial Variability and Application of Ratios between BTEX in Two Canadian Cities
Published 2011-01-01Get full text
Article -
56
Characterizing Radon Among Public Buildings and Small/Medium-Sized Businesses in a Canadian Province
Published 2024-12-01“…The radon measurements ranged from <4 to 566 Bq/m<sup>3</sup>, with a median of 26 Bq/m<sup>3</sup>, arithmetic mean of 40.2 Bq/m<sup>3</sup>, and geometric mean of 26.9 Bq/m<sup>3</sup>. Using the Health Canada and Ontario labor guideline of 200 Bq/m<sup>3</sup>, 2.5% of participating workplaces had at least one measurement above this level; 7.2% were above the World Health Organization guideline. …”
Get full text
Article -
57
Percutaneous vacuum-assisted tumor thrombectomy using angiovac and penumbra lightning 12 aspiration systems
Published 2025-04-01“…The patient's disease was not amenable to surgical resection and thrombolytic therapy was contraindicated due to associated intratumor hemorrhage, thus prompting consideration of thrombectomy under emergency approval from Health Canada. The patient underwent an overall successful total aspiration thrombectomy of the intracardiac tumor thrombus with subsequent resolution of her right heart strain, using the extracorporeal AngioVac aspiration system and partial aspiration of the extensive pulmonary emboli using the Penumbra Indigo Lightning 12 system. …”
Get full text
Article -
58
Improving predictability of IgE-high type 2 chronic sinusitis with nasal polyps in the biologic era
Published 2022-05-01“…Omalizumab is an anti-IgE biologic that was recently approved by the FDA and Health Canada for use in severe CRS with nasal polyps (CRSwNP) recalcitrant to intranasal corticosteroids. …”
Get full text
Article -
59
-
60
Comparative, cross-sectional study of the format, content and timing of medication safety letters issued in Canada, the USA and the UK
Published 2018-10-01“…Objectives To assess consistency in the format and content, and overlap of subject and timing, of medication safety letters issued by regulatory health authorities to healthcare providers in Canada, the USA and the UK.Design A cross-sectional study comparing medication safety letters issued for the purpose of alerting healthcare providers to newly identified medication problems associated with medications already on the market.Setting Online databases operated by Health Canada, the US Food and Drug Administration and the UK Medicines and Healthcare products Regulatory Agency were searched to select medication safety letters issued between 1 January 2010 and 31 December 2014. …”
Get full text
Article